| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GIT 27 |
|---|
| Description | Orally active immunomodulatory agent that primarily targets macrophages. Inhibits TNF-α secretion via interference of macrophage toll-like receptor (TLR) 4 and TLR 2/6 signaling pathway. Also reduces the secretion of pro-inflammatory cytokines IL1-β, IL-10 and IFN-γ. Antidiabetogenic; prevents IL-β and IFN-γ-induced pancreatic islet cell death in vitro. Purity 99%. MW (observed): 205.21 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4,5-Dihydro-3-phenyl-5-isoxazoleacetic acid |
|---|
| Gene, Accession, CAS # | CAS: 6501-72-0 |
|---|
| Catalog # | 3270/50 |
|---|
| Price | |
|---|
| Order / More Info | GIT 27 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 25950482 |
|---|
| 產(chǎn)品資料 |
|
|